Results 221 to 230 of about 2,054,798 (317)

Computer-Aided Design and Additive Manufacturing for Automotive Prototypes: A Review [PDF]

Marcos Vido, Geraldo Cardoso de Oliveira Neto, Sérgio Ricardo Lourenço, Marlene Amorim, Mário Rodrigues   +4 more
openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Correction to "Additive Zirconia in Dentistry: Techniques, Trends, and Future Perspectives". [PDF]

Biomed Res Int
europepmc   +1 more source

Assessment of the feed additive consisting of L-cysteine hydrochloride monohydrate (2b920) for cats and dogs for the renewal of its authorisation (PRINOVA BENELUX AND FRANCE N.V). [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Röhe I, Theodoridou K, Anguita Freixa M, Innocenti ML, Pizzo F, Tarrés-Call J.   +20 more
europepmc   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Industrial Validation and Mechanical Characterization of SMA Mixtures Stabilized with Recycled Polymeric Fibers from Waste Tires. [PDF]

Polymers (Basel)
Calabi-Floody A, Valdés-Vidal G, Mignolet-Garrido C, Díaz-Montecinos C, Fonseca-Ibarra C.   +4 more
europepmc   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Safety and efficacy of a feed additive consisting of alpha-galactosidase (produced with <i>Aspergillus tubingensis</i>ATCC SD 6740) and endo-1,4-beta-xylanase (produced with <i>Trichoderma orientale</i>CBS 139997) (Capsozyme SB Plus) for turkeys for fattening and reared for breeding (Industrial Técnica Pecuaria, S.A.). [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Röhe I, Theodoridou K, Brantom P, Anguita M, Galobart J, L Innocenti M, Pettenati E, Pizzo F, Brozzi R.   +23 more
europepmc   +1 more source